Hypothesis / aims of study
Development of the tethered spinal cord syndrome secondary genesis may be due to the consequences and complications in the fetal and neonatal periods of spina bifida aperta surgical treatment. Currently, a wide range of criteria and indications for surgical Spinal Myelodysplasia (SM) retethering described in the first part of the review, as well as a range of technologies and options for surgical treatment of STSC in spina bifida, allows us to state the need both to prevent the "symptomatic stage" of secondary spinal cord fixation syndrome and motivates the authors and other researchers for further study and evaluation of each and every result and minimal clinical efficacy criteria. The authors present this review as the first sage for the systematic analysis of the neurosurgical treatment and "symptomatic" criteria and SM retethering in SB efficiency.
Study design, materials and methods
The search for prospective cohort clinical studies was carried out in the Pubmed, EMBASE, eLibrary and the Library databases, published in the period from 2005 - August 2022, evaluating the methods of the fixed spinal cord syndrome correction in Spina bifida. Two researchers carried out the search for literature data. The study was carried out in accordance with the international guidelines for writing systematic reviews and meta - analyses of PRISMA.
Interpretation of results
Currently there is a consensus among the experts regarding clinical and neuro visualization criteria of tethered cord syndrome. Despite that, the question of surgical effectiveness directly depends on methods of clinical evaluation used to assess severity of functional deficit (that includes voiding function) and to what degree morpho functional alterations to neural tissue are reversible.
Despite the abundance of clinical scores and questionnaires currently there is no universally implemented system for standardized evaluation of neurologic, urologic and orthopedic deficits in patients with tethered cord syndrome.